Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China [Original Articles]

Conclusions:
Early intravenous TCM use for AMI in China is increasing despite the lack of evidence of their benefit or harm. There is an urgent need to define the effects of these medications because they have become a staple of treatment in the world’s most populous country.

CLINICAL TRIAL REGISTRATION:
URL: https://www.clinicaltrials.gov. Unique identifier: NCT01624883

Source: Circulation: Cardiovascular Quality and Outcomes - March 16, 2018 Category: Cardiology Authors: Spatz, E. S., Wang, Y., Beckman, A. L., Wu, X., Lu, Y., Du, X., Li, J., Xu, X., Davidson, P. M., Masoudi, F. A., Spertus, J. A., Krumholz, H. M., Jiang, L. Tags: Myocardial Infarction, Quality and Outcomes Original Articles Source Type: research